| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $43K | +0.0% |
| R&D Expense | $74.5M | +5.8% |
| SG&A Expense | $22.3M | -3.6% |
| Operating Income | -$96.8M | -3.5% |
| Income Tax | $0 | — |
| Net Income | -$141.0M | -105.2% |
| EPS (Basic) | -$1.86 | -14.8% |
| EPS (Diluted) | -$1.86 | -14.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $81.5M | +20.9% |
| Inventory | $73K | +0.0% |
| Current Assets | $87.6M | +22.0% |
| Total Assets | $121.4M | +12.3% |
| Current Liabilities | $18.3M | -7.3% |
| Total Liabilities | $111.9M | +40.5% |
| Stockholders' Equity | $9.5M | -66.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$90.3M | -37.9% |
| Capital Expenditures | $557K | -68.4% |
| Investing Cash Flow | -$557K | +68.4% |
| Financing Cash Flow | $105.0M | +3.7% |
| Free Cash Flow | -$90.9M | -35.1% |